The environment and kidney health: challenges and opportunities.


Journal

Salud publica de Mexico
ISSN: 1606-7916
Titre abrégé: Salud Publica Mex
Pays: Mexico
ID NLM: 0404371

Informations de publication

Date de publication:
13 Jun 2022
Historique:
received: 04 05 2021
accepted: 05 10 2021
entrez: 21 9 2022
pubmed: 22 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

The accelerating environmental degradation as a result of modernisation and climate change is an urgent threat to human health. Environment change can impact kidney health in a variety of ways such as water scarcity, global heating and changing biodiversity. Ever increasing industrialization of health care has a large carbon footprint, with dialysis being a major contributor. There have been calls for all stakeholders to adopt a 'one health approach' and develop mitigation and adaptation strategies to combat this challenge. Because of its exquisite sensitivity to various elements of environment change, kidney health can be a risk marker and a therapeutic target for such interventions. In this narrative review, we discuss the various mechanisms through which environmental change is linked to kidney health and the ways that the global kidney health communities can respond to environmental change.

Identifiants

pubmed: 36130396
doi: 10.21149/12799
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S46-S55

Auteurs

Joyita Bharati (J)

Post Graduate Institute of Medical Education and Research, Chandigarh, India. sharma.joyita4@gmail.com.

Carol Zavaleta-Cortijo (C)

Facultad de Salud Pública, Universidad Peruana Cayetano Heredia. Lima, Peru. carol.zavaleta.c@upch.pe.

Tiana Bressan (T)

School of Engineering, College of Engineering and Physical Sciences, University of Guelph. Guelph, Ontario, Canada. tbressan@uoguelph.ca.

Aakash Shingada (A)

Wockhardt Hospitals. Mumbai, India. aakashshingada@gmail.com.

Gregorio Obrador (G)

Universidad Panamericana, Escuela de Medicina. Mexico City, Mexico. gobrador@up.edu.mx.

Laura Sola (L)

Centro de diálisis, CASMU-IAMPP. Montevideo, Uruguay. solalaura11@gmail.com.

David Peiris (D)

The George Institute for Global Health, UNSW. Sydney, Australia. dpeiris@georgeinstitute.org.

J Jaime Miranda (JJ)

The George Institute for Global Health, UNSW. Sydney, Australia/Cronicas, Centro de Excelencia en Enfermedades Crónicas, Universidad Peruana Cayetano Heredia. Lima, Peru. jaime.miranda@upch.pe.

Vivekanand Jha (V)

George Institute for Global Health, UNSW. New Delhi, India/School of Public Health, Imperial College. London, UK/Manipal Academy of Higher Education. Manipal, India. vjha@georgeinstitute.org.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH